Because Nrf2 activation is widely recognized as a key mechanism for enhancing cellular defense against oxidative stress and inflammation [58, 59], and pharmacological Nrf2 activators can alleviate liver inflammation and fibrosis [60, 61]. The gene discussed is NFE2L2; the disease is Hepatitis.